Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Guidance

Subcategories:Clinical Criteria/GuidelinesEthicsLegal UpdatesLegislation & AdvocacyMeeting ReportsResearch Rheum

Figure 2: High-resolution computed tomography showed evidence of interstitial lung disease.

High-resolution computed tomography shows evidence of ILD.

The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!

 

8 Steps To Produce Successful Clinical Vignette Submissions

Alfred Burger, MD, Elizabeth A. Paesch, MD, and Chad S. Miller, MD  |  November 2, 2014

Tips to recognize a good case, conduct a literature search and develop teaching points

Gout, Glucose Metabolism and Obesity: A Case Review

Lindsey A. MacFarlane, MD, Daniel H. Solomon, MD, MPH, and Seoyoung C. Kim, MD, ScD, MSCE  |  November 2, 2014

New research explores association between hyperurecimia and gout with metabolic derangement

What the Healthcare System Can Learn from the World of Bees

Rick Brasington, MD  |  November 1, 2014

Bees’ natural instinct to promote health of whole colony could inspire healthcare professionals to work together toward common good

2014 ACR Awards of Distinction, Masters & ARHP Merit & Lifetime Achievement Awards Announced

From the College  |  November 1, 2014

Award winners to be recognized at Nov. 15 ceremony before start of the ACR/ARHP Annual Meeting in Boston

The ACR Seeks to Expand Engagement, Influence Among State Legislators

Staff  |  November 1, 2014

Members encouraged to advocate for rheumatology with elected officials in their home districts

Rheumatology Research Foundation Backs Need to Accelerate New Medicines for Lupus

Staff  |  November 1, 2014

Foundation appeals to Congressional lawmakers for support of biomedical innovation to battle lupus

Are Insurance Companies’ Medication Directives Fiscally, Medically Questionable?

Bruce Rothschild, MD  |  November 1, 2014

A reader questions whether insurers’ practice of promoting medications has undermined physicians’ ability to provide quality patient care

The ACR President Joseph Flood, MD, Reviews 2014 in Rheumatology

Joseph Flood, MD  |  November 1, 2014

Information technology an overarching theme of this year’s work

New Assay Aids In Evaluating Metabolic Effects of Glucocorticoids

Lara C. Pullen, PhD  |  October 31, 2014

Test measures efficacy of compounds for treating arthritis and their effect on glucose kinetics

New Research Points to Possible Future Treatment Option for Alopecia Areata

Lara C. Pullen, PhD  |  October 24, 2014

Topical application of protein tyrosine kinase inhibitors shown to reverse mouse model of the disease

  • « Previous Page
  • 1
  • …
  • 219
  • 220
  • 221
  • 222
  • 223
  • …
  • 309
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences